Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P
Cancers (Basel). 2025; 17(5).
PMID: 40075679
PMC: 11899103.
DOI: 10.3390/cancers17050832.
Ganesan I, Kiyokawa H
Cancers (Basel). 2025; 17(4).
PMID: 40002221
PMC: 11853300.
DOI: 10.3390/cancers17040626.
Fechtmeyer P, Yeh J
bioRxiv. 2024; .
PMID: 39677683
PMC: 11643031.
DOI: 10.1101/2024.12.07.627262.
Fu S, Cheng K, Hsiao C, Fang Y, Jeng C, Tang C
Cell Commun Signal. 2024; 22(1):571.
PMID: 39609819
PMC: 11603662.
DOI: 10.1186/s12964-024-01960-9.
Pauzaite T, Nathan J
Biochem Soc Trans. 2024; 52(6):2253-2265.
PMID: 39584532
PMC: 11668284.
DOI: 10.1042/BST20230861.
Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells.
Pratummanee K, Kerdkumthong K, Roytrakul S, Tantimetta P, Runsaeng P, Saeheng S
Mol Med Rep. 2024; 30(5).
PMID: 39239747
PMC: 11406421.
DOI: 10.3892/mmr.2024.13322.
Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.
Lu K, Zhou X
Sci Signal. 2024; 17(841):eadi8743.
PMID: 38889227
PMC: 11409840.
DOI: 10.1126/scisignal.adi8743.
Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Jeong J, Usman M, Li Y, Zhou X, Lu K
Cells. 2024; 13(9.
PMID: 38727267
PMC: 11083468.
DOI: 10.3390/cells13090731.
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression.
Kowald L, Roedig J, Karlowitz R, Wagner K, Smith S, Juretschke T
Cell Death Discov. 2024; 10(1):128.
PMID: 38467608
PMC: 10928094.
DOI: 10.1038/s41420-024-01894-8.
Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells.
Zhu Q, Liang P, Meng H, Li F, Miao W, Chu C
Nat Commun. 2024; 15(1):40.
PMID: 38167292
PMC: 10762127.
DOI: 10.1038/s41467-023-44349-x.
KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.
Yao L, Hao Q, Wang M, Chen Y, Cao H, Zhang Q
Oncogene. 2023; 42(47):3514-3528.
PMID: 37845393
PMC: 10656286.
DOI: 10.1038/s41388-023-02858-5.
PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target.
Singh S, Yeat N, Wang Y, Lin S, Kuo I, Wu K
Cell Death Dis. 2023; 14(10):671.
PMID: 37821451
PMC: 10567730.
DOI: 10.1038/s41419-023-06201-4.
The PML hub: An emerging actor of leukemia therapies.
Rerolle D, de The H
J Exp Med. 2023; 220(8).
PMID: 37382966
PMC: 10309189.
DOI: 10.1084/jem.20221213.
NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation.
Zhang P, Chen L, Zhou F, He Z, Wang G, Luo Y
Cell Death Dis. 2023; 14(2):159.
PMID: 36841806
PMC: 9958327.
DOI: 10.1038/s41419-023-05696-1.
PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions.
Chen J, Li M, Liu Y, Guan T, Yang X, Wen Y
Cell Death Differ. 2023; 30(4):1082-1095.
PMID: 36813923
PMC: 10070344.
DOI: 10.1038/s41418-023-01128-x.
The roles of KLHL family members in human cancers.
Ye G, Wang J, Yang W, Li J, Ye M, Jin X
Am J Cancer Res. 2022; 12(11):5105-5139.
PMID: 36504893
PMC: 9729911.
The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.
Park J, Kim D, Kim J, Jo J, Kim Y, Jung D
Biochem Biophys Res Commun. 2022; 636(Pt 2):71-78.
PMID: 36368157
PMC: 9671844.
DOI: 10.1016/j.bbrc.2022.10.108.
A synthetic KLHL20 ligand to validate CUL3 as a potent E3 ligase for targeted protein degradation.
Farrell B, Gerth F, Yang C, Yeh J
Genes Dev. 2022; 36(17-18):1031-1042.
PMID: 36328355
PMC: 9732910.
DOI: 10.1101/gad.349717.122.
The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy.
Chen Y, Hou X, Pang J, Yang F, Li A, Lin S
Front Mol Neurosci. 2022; 15:1006419.
PMID: 36304997
PMC: 9592815.
DOI: 10.3389/fnmol.2022.1006419.
Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics.
Zhan X, Lu M, Yang L, Yang J, Zhan X, Zheng S
Front Endocrinol (Lausanne). 2022; 13:970843.
PMID: 36187110
PMC: 9520991.
DOI: 10.3389/fendo.2022.970843.